Beyond the Headline: How Whitehawk''s AACR 2026 ADC Portfolio Signals a Shift
Whitehawk Therapeutics'' planned presentation of its next-generation ADC
Corporate strategy, M&A activity, and business development in the commerce sector.
Whitehawk Therapeutics'' planned presentation of its next-generation ADC
XCMG''s participation in CONEXPO-CON/AGG 2026 was more than a simple trade
XCMG''s presence at CONEXPO-CON/AGG 2026 was more than a product showcase;
YY Group's strategic investment in Arros AI, announced in March 2026, is
ZTO Express''s 2025 financial results, featuring a RMB 9.5 billion adjusted
The Q1 2026 dividend declarations from PepsiCo and Tri-County Financial Group,